deucravacitinib,apremilast
bms,amgen
['psoriasis', 'deucrava', 'deucra']
u.s. food and drug administration approves sotyktu (deucravacitinib), oral treatment for adults with moderate-to-severe plaque psoriasis 
#Stocks News Feed provides Stock Market News, and Press Releases from several sources in one feed. As an affiliate, we earn from qualifying purchases.